Reply to the Letter to the Editor "Is it time to abandon drugeluting stents for saphenous venous graft percutaneous coronary intervention?"

Islam Y. Elgendy; Ahmed N. Mahmoud; Emmanouil S. Brilakis; Anthony A. Bavry

doi:10.4244/EIJ-D-18-00666R

Reply to the Letter to the Editor "Is it time to abandon drugeluting stents for saphenous venous graft percutaneous coronary intervention?"

Islam Y. Elgendy, Ahmed N. Mahmoud, Emmanouil S. Brilakis, Anthony A. Bavry

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	211-212
Number of pages	2
Journal	EuroIntervention
Volume	15
Issue number	2
DOIs	https://doi.org/10.4244/EIJ-D-18-00666R
State	Published - Jun 2019
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.4244/EIJ-D-18-00666R

Cite this

@article{9e87ef63ea6444eda66957105182df6a,

title = "Reply to the Letter to the Editor {"}Is it time to abandon drugeluting stents for saphenous venous graft percutaneous coronary intervention?{"}",

author = "Elgendy, {Islam Y.} and Mahmoud, {Ahmed N.} and Brilakis, {Emmanouil S.} and Bavry, {Anthony A.}",

note = "Funding Information: E. Brilakis reports consulting/speaker honoraria from Abbott Vascular, Amgen, Asahi, CSI, Elsevier, GE Healthcare, and Medicure, research support from Boston Scientific and Osprey,",

year = "2019",

month = jun,

doi = "10.4244/EIJ-D-18-00666R",

language = "English (US)",

volume = "15",

pages = "211--212",

journal = "EuroIntervention",

issn = "1774-024X",

publisher = "EuroPCR",

number = "2",

}

TY - JOUR

T1 - Reply to the Letter to the Editor "Is it time to abandon drugeluting stents for saphenous venous graft percutaneous coronary intervention?"

AU - Elgendy, Islam Y.

AU - Mahmoud, Ahmed N.

AU - Brilakis, Emmanouil S.

AU - Bavry, Anthony A.

N1 - Funding Information: E. Brilakis reports consulting/speaker honoraria from Abbott Vascular, Amgen, Asahi, CSI, Elsevier, GE Healthcare, and Medicure, research support from Boston Scientific and Osprey,

PY - 2019/6

Y1 - 2019/6

UR - http://www.scopus.com/inward/record.url?scp=85113304701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85113304701&partnerID=8YFLogxK

U2 - 10.4244/EIJ-D-18-00666R

DO - 10.4244/EIJ-D-18-00666R

M3 - Letter

C2 - 31217156

AN - SCOPUS:85113304701

SN - 1774-024X

VL - 15

SP - 211

EP - 212

JO - EuroIntervention

JF - EuroIntervention

IS - 2

ER -

Reply to the Letter to the Editor "Is it time to abandon drugeluting stents for saphenous venous graft percutaneous coronary intervention?"

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this